Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocort versus Depo-Medrol for active rheumatoid arthritis flare
2015-002924-17Phase 3Terminated
- Sponsor
- Sun Pharma
- Start
- Oct 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydrocortisone and methylprednisolone in rheumatoid arthritis (RA) (2 arms), sponsored by Sun Pharma. Primary endpoint: EULAR responder rate at Week 1. Started Oct 2015; status: terminated.
02
Drugs
hydrocortisonemethylprednisolone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2015-002924-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002924-17.